Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, Jilin 130041, China.
Department of Radiotherapy, Second Hospital of Jilin University, Changchun, Jilin 130041, China.
Chin Med J (Engl). 2023 May 20;136(10):1155-1165. doi: 10.1097/CM9.0000000000002641. Epub 2023 Mar 17.
Hepatocellular carcinoma (HCC) is the most common type of primary hepatocellular carcinoma (PHC). Early diagnosis of HCC remains the key to improve the prognosis. In recent years, with the promotion of the concept of precision medicine and more in-depth analysis of the biological mechanism underlying HCC, new diagnostic methods, including emerging serum markers, liquid biopsies, molecular diagnosis, and advances in imaging (novel contrast agents and radiomics), have emerged one after another. Herein, we reviewed and analyzed scientific advances in the early diagnosis of HCC and discussed their application and shortcomings. This review aimed to provide a reference for scientific research and clinical practice of HCC.
肝细胞癌(HCC)是原发性肝癌(PHC)最常见的类型。HCC 的早期诊断仍然是改善预后的关键。近年来,随着精准医学理念的推广和对 HCC 生物学机制的更深入分析,包括新兴的血清标志物、液体活检、分子诊断和影像学(新型对比剂和放射组学)在内的新的诊断方法相继出现。在此,我们对 HCC 的早期诊断的科学进展进行了回顾和分析,并讨论了它们的应用和不足。本综述旨在为 HCC 的科学研究和临床实践提供参考。